IMAGE: Lung squamous cell carcinoma

Breaking News

Public Release: 1-Aug-2013
Cell Reports
Novel drug shuts down master protein key to lymphoma
Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, itself the seventh most frequently diagnosed cancer in the US.
NIH/National Cancer Institute, National Science Foundation, Chemotherapy Foundation

Contact: John Rodgers
jdr2001@med.cornell.edu
646-317-7401
Weill Cornell Medical College

Public Release: 1-Aug-2013
PLOS Genetics
Genetics: More than merely a mutated gene
If two women have the same genetic mutation that puts them at higher-than-average risk for a disease such as breast cancer, why does only one develop the disease?
National Science Foundation

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Public Release: 1-Aug-2013
ASTRO applauds new GAO report on physician self-referral abuse
ASTRO Chairman Michael L. Steinberg, M.D., FASTRO, called attention to the Government Accountability Office's striking report released today, "Medicare: Higher Use of Costly Prostate Cancer Treatment by Providers Who Self-Refer Warrants Scrutiny," that details clear mistreatment of patients who trusted their physicians to care for their prostate cancer.

Contact: Michelle Kirkwood
michellek@astro.org
703-286-1600
American Society for Radiation Oncology

Latest Multimedia

Richard I. Fisher, Fox Chase Cancer Center

Richard I. Fisher, Fox Chase Cancer Center
This is Richard I. Fisher, M.D., who was named president and CEO of Fox Chase Cancer Center.

Contact: Diana Quattrone
diana.quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center

Maintenance Therapy for Metastatic Colorectal Cancer: Practice before Evidence?

Maintenance Therapy for Metastatic Colorectal Cancer: Practice before Evidence?
F. Ciardiello shares his comments on perspectives and potentials to change the current practice in the management of metastatic colorectal cancer, based on results from two studies on maintenance ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Nationwide NSCLC Study Provides Data on the Value of Molecular Screening for Targeted Treatment

Nationwide NSCLC Study Provides Data on the Value of Molecular Screening for Targeted Treatment
R. Dziadziuszko underlines the importance of widening the range of screened biomarkers, the potential benefits in terms of treatment appropriateness for patients and the added value of broad ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

  Search News Releases

     

 

 

EurekAlert!